Zur Rose Group AG successfully completes CHF 212 million capital increase

Frankfurt am Main, 17 July 2020. Zur Rose Group AG (the “Company” or “Zur Rose Group”) successfully completed the capital increase that was resolved yesterday. A total of 740,823 new shares were sold in an international private placement to institutional investors at a placement price of CHF 287.00 per new share (the “Placement Price”).

Continue Reading

Zur Rose Group acquires TeleClinic, Germany’s leading telemedicine provider

Frankfurt am Main, 17 July 2020.

From diagnosis to delivery
Telemedicine pioneer TeleClinic offering reimbursable consultation services compliant with German national health insurance scheme
TeleClinic continuously expanding its time to market lead in the post-COVID-19 time
Telemedicine to form an important element in Zur Rose healthcare ecosystem, serving as additional entry point for digital customer journey
Doctors are given the opportunity to offer their expertise more flexible and independent of location
Both companies’ core businesses are further strengthened through highly complementary competencies with regard to the electronic prescription (eRx)

Continue Reading

ACXIT Capital Partners strengthens its financial sponsor coverage with Lars T. Rückert, Managing Director

Frankfurt am Main, 08 July 2020. ACXIT Capital Partners, a leading independent European corporate finance and financial advisory firm, is pleased to announce the addition of senior banker Lars T. Rückert to its financial sponsor practice. He is one of the bespoken industry experts in this field with profound understanding of corporate finance, M&A and capital markets as well as special experience in portfolio company management in the consumer/retail and e-commerce sector.

Continue Reading

ZUR ROSE GROUP STRENGTHENS EUROPEAN MARKET LEADERSHIP THROUGH ACQUISITION OF MAIL-ORDER AND DIABETES ACTIVITIES OF APOTAL GROUP

Frankfurt am Main, 26 June 2020

– Further expansion of European market leadership and #1 position in Germany with now more than 8 million active customers (1)
– Improved pole position to benefit from eRx introduction and to serve as future launch pad for telemedicine and ehealth ecosystem
– Financing through available cash and issuance of shares

Continue Reading

ACXIT Capital Partners acted as exclusive M&A and financial advisor for the transfer of the Private University of Göttingen (PFH) as part of the K4 Group to Galileo Global Education Germany

Frankfurt. After 25 years of successful development, the shareholders of the K4 Group handed over the university-related educational companies and their sister company Private Hochschule Göttingen (PFH) to Galileo Global Education Germany on February 1, 2020. The focus was on accelerating the development of the university and strengthening its leading role in distance learning with the synergies of the sister companies.

Continue Reading

ACXIT Capital Partners advised Zur Rose Group on the successful placement of CHF 175M Convertible Bonds

Frankfurt, 30 March 2020. Zur Rose Group AG (the “Company” or “Zur Rose”), via its subsidiary Zur Rose Finance B.V. (the “Issuer”), successfully completed the placement of senior unsecured bonds due 2025 (the “Bonds”), guaranteed by the Company and convertible into registered shares of the Company (the “Shares”).

Continue Reading